New 5-FU Derivative EB-18 Shows Potency Against Resistant Cancers
Researchers have engineered EB-18, a phosphonium-substituted derivative of the classic chemotherapy drug 5-fluorouracil that outperforms 5-FU and standard agents in ...
Researchers have engineered EB-18, a phosphonium-substituted derivative of the classic chemotherapy drug 5-fluorouracil that outperforms 5-FU and standard agents in ...
New research in Nature Cancer shows that the common commensal fungus Nakaseomyces glabratus is enriched in the feces and tumors ...
Low-dose inhibition of the motor protein KIF11 rebuilds enhancer–promoter loops at the androgen receptor locus, restoring drug sensitivity in otherwise ...
Prostate cancer remains one of the most prevalent malignancies among men, with significant morbidity and mortality rates worldwide. At the ...
In the evolving landscape of oncology, the intricate interactions between oncogenic pathways are gaining unprecedented attention. At the forefront of ...
In the relentless battle against prostate cancer, a beacon of hope emerges from the ancient spice turmeric. A newly published ...
A groundbreaking study published recently in the prestigious journal Oncotarget has unveiled a novel therapeutic strategy against castration-resistant prostate cancer ...
In a groundbreaking effort to redefine treatment paradigms for oligometastatic prostate cancer (OMPC), researchers have launched a multicenter, randomized controlled ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine